Oxigene and Dynavax warned of Nasdaq delisting
This article was originally published in Scrip
Executive Summary
Nasdaq has issued letters to Oxigene and Dynavax informing the companies that they are breaching its Global Market rule of having at least $10 million in stockholder equity.